Rockwell Medical Inc RMTI

Morningstar Rating
$8.22 +0.57 (7.45%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RMTI is trading at a LOCK|g<rFG premium.
Price
$7.65
Fair Value
LOCK|.?%?&T
Uncertainty
LOCK|@Bj
1-Star Price
LOCK|.$%H#&^W
5-Star Price
LOCK|?g!#^dd
Economic Moat
LOCK|^%<
Capital Allocation
—

News

Trading Information

Previous Close Price
$7.65
Day Range
$7.68–8.31
52-Week Range
$4.89–12.90
Bid/Ask
$8.06 / $8.35
Shares Outstanding
4.03M
Market Cap
$33.13M
Volume/Avg
52,565 / 27,817

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.43
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
157

Valuation

Metric
RMTI
Price/Earnings (Normalized)
—
Price/Book Value
0.87
Price/Sales
0.43
Price/Cash Flow
36.30
Price/Earnings
RMTI

Financial Strength

Metric
RMTI
Quick Ratio
2.96
Current Ratio
3.25
Interest Coverage
−3.64
Quick Ratio
RMTI

Profitability

Metric
RMTI
Return on Assets (Normalized)
−6.16%
Return on Equity (Normalized)
−9.88%
Return on Invested Capital (Normalized)
−5.15%
Return on Assets
RMTI

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|$Jg!!@!!LOCK|<HML$68B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|&lhNnrWLOCK|z<fGv$46B
Haleon PLC ADR
HLN
LOCK|^B?f>gLOCK|YM$39B
Zoetis Inc Class A
ZTS
LOCK|d&StFxRRLOCK|Nr$29B
Viatris Inc
VTRS
LOCK|ZTWk!>fLOCK|#@@$20B
Elanco Animal Health Inc
ELAN
LOCK|C>LOCK|xG$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|dsNRy^LOCK|tG<$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|dQ!j!QPLOCK|<@$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|VsNd@#LOCK|XlYf$2B
Perrigo Co PLC
PRGO
LOCK|YL&!dt%LOCK|<#$2B

Sponsor Center